| Literature DB >> 34769419 |
Ashvi Sanjay Jain1, Pranita Subhash Pawar1, Aira Sarkar2, Vijayabhaskarreddy Junnuthula3, Sathish Dyawanapelly1.
Abstract
Among the various types of nanoparticles and their strategy for synthesis, the green synthesis of silver nanoparticles has gained much attention in the biomedical, cellular imaging, cosmetics, drug delivery, food, and agrochemical industries due to their unique physicochemical and biological properties. The green synthesis strategies incorporate the use of plant extracts, living organisms, or biomolecules as bioreducing and biocapping agents, also known as bionanofactories for the synthesis of nanoparticles. The use of green chemistry is ecofriendly, biocompatible, nontoxic, and cost-effective. We shed light on the recent advances in green synthesis and physicochemical properties of green silver nanoparticles by considering the outcomes from recent studies applying SEM, TEM, AFM, UV/Vis spectrophotometry, FTIR, and XRD techniques. Furthermore, we cover the antibacterial, antifungal, and antiparasitic activities of silver nanoparticles.Entities:
Keywords: biocapping agent; biomedical; bionanofactories; bioreduction; green synthesis; silver nanoparticles
Mesh:
Substances:
Year: 2021 PMID: 34769419 PMCID: PMC8584914 DOI: 10.3390/ijms222111993
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Antimicrobial mechanism of silver nanoparticles: (1) inhibition of DNA synthesis, (2) inhibition of mRNA synthesis, (3) cell membrane destruction and the leakage of the cell constituents, (4) inhibition of protein synthesis, (5) inhibition of cell-wall synthesis, (6) mitochondrial damage, and (7) inhibition of electron transport chain.
Figure 2Green synthesis of nanoparticles of silver nanoparticles.
Use of bionanofactories in the synthesis of silver nanoparticles, along with a brief outline of their physicochemical and antimicrobial properties.
| Category of Biofactories | Reducing Agent | UV/Vis | FTIR (cm−1) | Structural Analysis | In Vitro Activity Studies | Ref. |
|---|---|---|---|---|---|---|
| Green Algae |
| 403 nm (<6 h), 443 nm (after 24 h) | 3278, 1634, 1539 | AFM For AgNPs ( For AgNPs ( Crystalline Structure—face-centered cubic (FCC) AgNPs ( AgNPs ( |
Antimicrobial efficacy against species such as | [ |
|
| 420–430 nm | 3423, 2927, 1645, 1515, 1429 | XRD Face-centered cubic (FCC) Average size ~35 nm Shape—uniform and quasi-spherical |
Antibacterial | [ | |
| Brown Algae |
| 440 nm | 1638, 1034, 3447, 1034.95, 1384.14 | SEM Shape—spherical to oval Size—32 to 51 nm Shape—mostly spherical Size—20 to 46 nm Crystalline Structure—face-centered cubic (FCC) Strong signal indicating presence of metallic silver |
Agar bioassay method showed reduction of bacterial colonies of | [ |
| Red Algae |
| 450 nm | 3907, 3779, 3410, 2927, 2853, 2593, 1644, 1416, 1170, 749 | HR-TEM Shape—variable shapes such as spherical, triangle, pseudo-spherical, and some rounded rectangle shapes Most observed shape and size—spherical and 5 to 50 nm Average size of NPs—32.70 nm Crystalline Structure—face-centered cubic (FCC) | Antibacterial activity of AgNPs (concentration = 100 μg/mL) In In | [ |
|
| 424 nm; | 2921, | EDS Optical absorption peak observed at 3 keV is typical for the absorption of metallic silver Crystalline Structure—Face-centered cubic (FCC) Size range = 10–35 nm |
Cytotoxic activity—on Hep2 cell lines, IC50 = 62.5 μg/mL | [ | |
| Blue-Green Algae | 419 nm | 3443.96, 3385.61, 2923.83, | SEM Shape—spherical Average size 51–100 nm Spherical and well-dispersed. Structure—face-centered cubic Nature—crystalline Nature—crystalline |
No significant cytotoxicity against MCF-7 breast cancer cells at lower concentration; cytotoxicity increased with increasing concentration from 0 μL/mL to 50 μL/mL Good antibacterial and antifungal activity | [ | |
| 420 nm | 3383.72, 2930.60, 1651.13, 1076.58 | TEM Size: 10–50 nm Nature—crystalline Structure—face-centered cubic (FCC) Calculated particle size—20 nm |
Ag-CNP treatment inhibited growth of tumor and cancer cells and induced apoptosis | [ | ||
| Actinomycetes |
| - | 3421, 1384.4, 1623, 1480 | TEM Spherical shape Indicated Ag as the major element with a ~3 keV signal Heterogeneous particle size distribution observed in the range of ~8–48 nm. |
Antimicrobial activity against the tested strains such as Synergistic effects of bio(AgNPs) with various standard antibiotics | [ |
|
| 410 nm | 3420.14, | EDS Optical absorption peak for AgNPs observed at 3.5 keV Size: 22 to 85 nm |
AgNPs exhibited synergistic effects with antibiotics such as ciprofloxacin, ampicillin, streptomycin, gentamicin, tetracycline and lincomycin AgNPs reduced the density of bacterial cells and acted as an antibiofouling agent | [ | |
| 425 nm | 3695.61, 1585.49, 1398.39, 1151.50, 1068.56 | XRD Nature—crystalline Structure—face-centered cubic (FCC) Size range = 21–45 nm |
As compared to the cell-free supernatant, synthesized AgNPs showed high anticandidal activity | [ | ||
| 420 nm | 3440, 2923, 2853, 1655, 1460, 685 | SEM Average particle size ~45 ± 0.05 nm The optical absorption peak was observed at 3 keV Size range—30–90 nm Average particle size—45 ± 0.15 nm Shape—spherical |
Excellent antimicrobial activity by AgNPs observed against Cytotoxicity studies against HeLa cancer cell lines, IC50 = 200 | [ | ||
| Fungi |
| 420 nm | - | XRD Nature—crystalline Structure—face-centered cubic (FCC) Shape—spherical Average diameter—15.5 ± 2.5 nm Average diameter = 20.56 nm |
Potential antifungal activity against fungi such as Compared to antifungal drugs such as itraconazole and fluconazole, the biosynthesized AgNPs at concentrations near to 1 mg/mL showed a broader antifungal spectrum | [ |
| Mushroom | 400–470 nm | 3318, 2944, 1612, 1411 | HR-TEM and FE-SEM Shape—spherical in shape Average size range—10–40 nm Average size—28 nm 13% of Ag and rest presence of C & O recorded at 3 keV |
Antibacterial activity against Bactericidal activity observed against | [ | |
|
| 426 nm | 3145, 1597, 1402, 1109, 1213, 995, 911, 699, 504 | XRD Structure—face-centered cubic (FCC) Calculated mean size—~25 nm. Shape—spherical Size range—10–30 nm Nature—crystalline Strong silver peaks at 3 keV Monodispersed AgNPs, Average particle size 4 to 28 nm |
Antibacterial activity against human pathogenic bacteria such as | [ | |
| Endophytic fungus | 422 nm | 3430.86, 1573.16, | SEM Shape—spherical Size (diameter) range—10 to 50 nm Average size—26 nm Strong metal signal peak of Ag observed Structure—face-centered cubic (FCC) |
Synthesized AgNPs, along with antibiotics, exhibited inhibitory activity against Gram-negative and Gram-positive bacterial pathogens such as | [ | |
|
| 430 nm | 2920.23, 2850.79, | TEM Common shape—spherical Size range—10 to 15 nm Above size of 30 nm, hexagonal NPs Nature—crystalline Nature—crystalline Polydisperse AgNPs in the size range of 10–15 nm observed Absorption peak recorded at 3 keV |
Killing kinetic assay depicted that complete killing of | [ | |
| Bacteria | 428 nm | - | XRD Nature—crystalline Shape—spherical Size range—10 to 30 nm A peak recorded at 3 keV Average particles size—127 nm |
Activity efficiency observed in descending order against pathogens AgNPs at concentration of 5 μg/L found to inhibit biofilm formed by | [ | |
| 432 nm | - | FE-TEM Shape—spherical Size range—10 to 30 nm Highest peak recorded at 3 keV Nature—crystalline Average particle size—150.2 nm Polydispersity index (PDI)—0.176 |
Descending order of antimicrobial potential observed against AgNPs at a concentration of about 5–6 μg found to inhibit the biofilm formed by | [ | ||
|
| 413 nm | 1644, 1549, | FE-SEM Shape—spherical Average diameter range—10 to 30 nm Size range 10 to 30 nm |
Purified AgNPs showed relatively stronger antibacterial activity against | [ | |
| Halotolerant | 420 nm | 3400, 2969, | XRD Structure—face-centered cubic Shape—spherical Average size ~5.1 nm |
Antimicrobial activity observed against AgNPs showed broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative pathogens, as well as a fungus strain | [ | |
| 430 nm | 767, 1642, | TEM
Shape—different shapes, such as spherical and oval Size range—34 to 90 nmAFM Agglomerated silver nanostructures |
Gram-negative clinical pathogens showed a higher susceptibility to AgNPs than Gram-positive pathogens | [ | ||
| Plants (Roots) |
| 416 nm | 3354, 2952, 2063, 1651, 1419, 1383, | XRD Structure—face-centered cubic (FCC) Nature—crystalline Spherical shape and size not more than 85 nm |
Antibacterial activity observed against Susceptibility of dengue vector | [ |
|
| 417 nm and during reaction 436 nm | 3371–3377, | FE-TEM Shape—quasi-spherical Nature—well-dispersed and scattered Strong absorption peak recorded at 3 keV Structure—face-centered cubic Nature—crystalline |
Antibacterial activity observed against | [ | |
| 420 nm | - | SEM Shape—spherical Size range—70.7 to 192.02 nm (size varied with temperature) Structure—face-centered cubic (FCC) |
Minimal cytotoxicity to human PBMCs | [ | ||
| 460 nm | 3697, 3313, 3195, 2298, 1670, 1456, 1336, 1193, 1118, 811, | XRD Structure—face-centered cubic Nature—crystalline Shape—spherical Intense signal at 3 keV Stem extracts of Leaf extracts of Small-sized AgNPs: 4 to 14 nm Large-sized AgNPs: 20 to 50 nm |
Antibacterial activity—Stem and leaf synthesized AgNPs (at 50 | [ | ||
| Plants | Banana peel | 430nm | 2353–2351, 1732–1755, | SEM–EDS A distinct signal and high atomic percent values for silver were obtained Structure—face-centered cubic (FCC) Nature—crystalline |
AgNPs exhibited potent antifungal activity against the tested pathogenic strains of The antibacterial activity of AgNPs was observed against | [ |
| 435 nm | - | XRD Nature—crystalline Shape—spherical Particle size ~24.631 nm Shape—spherical shape Average size—22 nm |
Antimicrobial activity against | [ | ||
| Lemon | 400–430 nm | - | AFM Particle dimensions—height 12 nm, width 100 nm SEM—NPs consisted of agglomerates of small grains with diameter of approximately 75 nm |
Disc diffusion method showed that NPs reduced the growth of both | [ | |
| Other biosynthesizing Agents | Gum kondagogu ( | 416 nm | 3443, 2916, 2850, 1727, 1630, 1597, 1384, 1351, 1254, 1148, | TEM Shape—anisotropic nanostructures such as nanotriangles, a few nanorods, hexagonal and polygonal nanoprisms, and abundant unevenly shaped nanoparticles were observed Nature—polydisperse For 30 min of reaction time, size of 55.0 nm; for 60 min of reaction time, size of 18.9 nm Nature—crystalline Structure—face-centered cubic (FCC) Shape—spherical Average particle size: for 30 min of reaction time, 11.2 nm; for 60 min of reaction time, 4.5nm Nature—crystalline Structure—face-centered cubic |
Antibacterial activity was observed against | [ |
| Dextran T40 | 423 nm | - | AFM Particle size range—10 to 60 nm Shape—spherical Size ~5–10 nm Nature—crystalline. Optical absorption peak at 3 keV Structure—face-centered cubic (FCC) |
Antimicrobial activity observed against | [ | |
| Casein (milk protein) | 400 to 500 nm | 1644, 1514 | SEM and TEM Shape—spherical agglomerates formed upon carefully decreasing the pH to 3.32 Size—average diameter of about 60 to 80 nm |
AgNPs at a dose of 0.025 µg/mL, i.e., below LD50 value, was observed to be fairly distributed in cytoplasm of living cells imaged by CLSM | [ |
Sa—average roughness, Sq—root-mean-square roughness, Sz—ten-point height.
Figure 3Green synthesis of silver nanoparticles from bioreduction of silver ions. The first step involves the bioreduction of positive Ag+ into the zero-valent Ag0 metal, while the last step involves the stabilization of metal NPs.
Figure 4Green synthesis of AgNPs using leaf extract of P. hysterophorus. (A) The reduction of AgNO3 by P. hysterophorus extract indicated a color change after 5 min and 6 h. (B) Particle size distribution. (C) Anti-inflammatory activity of AgNPs according to (i) DPPH assay, (ii) H2O2 assay, (iii) NO free radical-scavenging assay, and (iv) nitric oxide radical-scavenging assay. (D) In vitro cytotoxicity test on B16F10 and HepG2 cell lines after 24 h and 48 h treatment; * p < 0.05, ** p < 0.01 and *** p < 0.001, unpaired Student’s t-test. CC-BY License [86].
Figure 5Nitrate reductase-mediated biogenic synthesis of AgNPs.
Figure 6FTIR spectra for PEG (A), [Ag(PEG)] for the stirring time of 48 h (B) and β-D-glucose (C). Figure was adopted from [198]; CC-BY License.